Treatment options for stage I nonseminoma Journal Article
| Author: | Feldman, D. R. |
| Article Title: | Treatment options for stage I nonseminoma |
| Abstract: | Three weeks ago, a healthy 29-year-old man underwent a left orchiectomy for a left testis mass revealing a 3-cm mixed nonseminomatous germ cell tumor composed of embryonal carcinoma and teratoma. Lymphovascular invasion was identified (Fig 1), but there was no invasion into the rete testis or other structures. Preoperative α-fetoprotein was elevated at 42 ng/mL but normalized to 3.5 ng/mL postoperatively. Human chorionic gonadotropin and lactate dehydrogenase were normal both before and after orchiectomy. A computed tomography scan of the chest, abdomen, and pelvis with contrast obtained 1 week ago revealed no evidence of retroperitoneal adenopathy or other sites of metastatic disease. The patient presents to see his physician, eager to discuss his treatment options and make a decision between adjuvant treatment and surveillance. |
| Keywords: | cancer survival; treatment outcome; survival rate; overall survival; cancer recurrence; cisplatin; cancer combination chemotherapy; systemic therapy; cancer adjuvant therapy; recurrence risk; follow up; antineoplastic agent; lymph node dissection; etoposide; bleomycin; embryonal carcinoma; retrograde ejaculation; recurrence free survival; disease surveillance; randomized controlled trial (topic); testis nonseminoma cancer; human; article |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 32 |
| Issue: | 34 |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2014-12-01 |
| Start Page: | 3797 |
| End Page: | 3800 |
| Language: | English |
| DOI: | 10.1200/jco.2014.56.8006 |
| PROVIDER: | scopus |
| PUBMED: | 25366681 |
| DOI/URL: | |
| Notes: | Export Date: 2 January 2015 -- Source: Scopus |
